Clin2
NCT07597928Likely a fitRecruiting

How Your Body Processes an Experimental Medicine

Healthy AdultsHealthy

Treatments studied

This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are in good overall health with no serious medical conditions
  • You are at least 18 years old
  • Your weight is healthy for your height (BMI between 16–32, and weighing more than 110 pounds)
  • You have not had HIV, hepatitis B, or hepatitis C
  • You have not abused alcohol or used illicit drugs in the past 6 months
  • You are not currently enrolled in any other drug or vaccine studies

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07519135Recruiting· Phase 1
Study of PF-08653944 in People With and Without Liver Problems

This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.

Miami Lakes, Florida
NCT07269301Recruiting· Phase 1
Liver function and study drug processing

This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.

Lake Forest, California
NCT07748026Not yet recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.

NCT07678463Recruiting· Phase 1
Testing a new medicine in healthy volunteers

This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.

Brisbane, Queensland
NCT06994897Recruiting· Phase 1
Safety and dosing study of PF-07985631 in healthy adults

This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.

Brussels, Bruxelles-capitale, Région de

Hear when a new Healthy Adults trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.